STOCK TITAN

Esperion to Participate in Upcoming Bank of America Securities 2022 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Esperion (NASDAQ: ESPR) has announced that its President and CEO, Sheldon Koenig, will present at the Bank of America Securities 2022 Healthcare Conference on May 10, 2022. The event is set to take place at 3:20 PM PT (6:20 PM ET) and will include both a presentation and individual meetings. Investors can access a live audio webcast through the company's website, with a replay available afterwards for 90 days. Esperion focuses on developing effective oral non-statin medications for cholesterol management, aiming to improve patient health outcomes.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., April 29, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10th, 2022.

Event:Bank of America Securities 2022 Healthcare Conference
Date:Tuesday, May 10th, 2022
Format:Presentation and 1:1 Meetings
Time:3:20 pm Pacific Time (6:20 pm ET)
Webcast:Link






A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.esperion.com/investor-relations/events. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

Esperion Therapeutics

Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Corporate Communications
corporateteam@esperion.com


FAQ

When will Esperion present at the Bank of America Securities Healthcare Conference?

Esperion will present at the Bank of America Securities Healthcare Conference on May 10, 2022.

What time is Esperion's presentation at the Healthcare Conference?

The presentation is scheduled for 3:20 PM PT (6:20 PM ET).

How can I access the webcast for Esperion's presentation?

The webcast can be accessed via the investor section of Esperion's website at www.esperion.com.

How long will the replay of Esperion's presentation be available?

The replay of the presentation will be available for approximately 90 days after the event.

What is the focus of Esperion in the pharmaceutical industry?

Esperion is focused on developing innovative oral medications to lower cholesterol, particularly for patients who do not respond to traditional treatments.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

476.49M
196.07M
0.5%
66.33%
17.05%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR